Published Studies Related to Xopenex Inhalation (Levalbuterol Inhalation)
Well-designed clinical trials related to Xopenex Inhalation (Levalbuterol Inhalation)
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. [2008.09]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2008]
Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. [2007.12]
An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. [2007.11]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2007.01.25]
Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial. [2006.06]
A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. [2006.05]
Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. [2005.07]
Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. [2005.07]
Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma. [2004.11]
An evaluation of nebulized levalbuterol in stable COPD. [2003.09]
The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. [1999.04]
Well-designed clinical trials possibly related to Xopenex Inhalation (Levalbuterol Inhalation)
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. [2008.10.29]
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. [2008.08.15]
Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study. [2008.08]
FEV1 response to bronchodilation in an adult urban population. [2008.08]
The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. [2008.06.01]
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. [2008.06]
Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD. [2008.06]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Inhaled salbutamol and doping control: effects of dose on urine concentrations. [2008.05]
Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma? [2008.05]
Comparison of nebulized epinephrine to albuterol in bronchiolitis. [2008.04]
Bronchodilator responsiveness in patients with COPD. [2008.04]
Aerosolized salbutamol accelerates the resolution of pulmonary edema after lung resection. [2008.04]
AIR inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics, and pulmonary function in asthma. [2008.04]
Efficacy and safety of fluticasone propionate/salmeterol 250/50mcg Diskus administered once daily. [2008.04]
Rapid corticosteroid effect on beta(2)-adrenergic airway and airway vascular reactivity in patients with mild asthma. [2008.03]
Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients. [2008.03]
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. [2008.01.01]
Dose response of inhaled salbutamol on exercise performance and urine concentrations. [2008.01]
Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists. [2008]
Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD. [2008]
Salmeterol/Fluticasone Propionate via Diskustrade mark Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids. [2008]
Agreement between two methods for assessing bioequivalence of inhaled salbutamol. [2008]
Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD. [2008]
Is Salamol less effective than Ventolin? A randomised, blinded, crossover study in New Zealand. [2007.12.14]
The Efficacy and Safety of Combination Salmeterol (50 {micro}g)/Fluticasone Propionate (500 {micro}g) Inhalation Twice Daily Via Accuhaler in Chinese Patients With COPD. [2007.12]
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. [2007.12]
Determination of the relative bioavailability of salbutamol to the lungs following inhalation from dry powder inhaler formulations containing drug substance manufactured by supercritical fluids and micronization. [2007.11]
Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures. [2007.11]
Comparison of traditional and abbreviated salbutamol aerosol therapy using a new spacer mouth mask. [2007.11]
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. [2007.11]
Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. [2007.10]
Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients. [2007.09]
Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. [2007.09]
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. [2007.09]
Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta2-agonists. [2007.08]
Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. [2007.07.04]
Randomized trial of spacers in asthma. [2007.07]
Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis. [2007.06.02]
Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. [2007.06]
A comparative study of patients' preferences and sensory perceptions of three forms of inhalers among Thai asthma and COPD patients. [2007.06]
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. [2007.05.17]
Randomized comparison of strategies for reducing treatment in mild persistent asthma. [2007.05.17]
A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma. [2007.05]
Evaluation of Albuterol 1.25 mg and 0.62 mg for Nebulization in 6- to 12-Year-Old Children With Moderately Severe Asthma. [2007.05]
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. [2007.04.17]
Effect of albuterol on maximal exercise capacity in cystic fibrosis. [2007.04]
The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD. [2007.04]
Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials. [2007.03.06]
A randomized, placebo-controlled trial of bronchodilators for bronchoscopy in patients with COPD. [2007.03]
Randomised trial comparing as-needed versus regular treatment with formoterol in patients with persistent asthma. [2007.03]
Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine-induced bronchoconstriction in children. [2007.03]
Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. [2007.03]
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. [2007.02.22]
Combination Therapy with a Long-Acting beta-Agonist and a Leukotriene Antagonist in Moderate Asthma. [2007.02.01]
Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. [2007.02]
Salmeterol enhances pulmonary fibrinolysis in healthy volunteers. [2007.01]
The correlation between asthma control and health status: the GOAL study. [2007.01]
Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma. [2007]
Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients. [2007]
Airway blood flow reactivity in smokers. [2007]
Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma. [2007]
Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline. [2007]
Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. [2006.12.04]
Management of acute asthma in children using metered dose inhaler and small volume nebulizer. [2006.12]
Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study. [2006.11]
Bronchial asthma as neurogenic paroxysmal inflammatory disease: A randomized trial with carbamazepine. [2006.11]
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma. [2006.10]
Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism. [2006.10]
Determinants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction. [2006.10]
Effect of formoterol fumarate treatment on exercise-induced bronchoconstriction in children. [2006.09]
Duration of action of the salmeterol/fluticasone combination inhaler administered in the evening: a randomized controlled trial in childhood asthma. [2006.09]
Inhaled steroid/long-acting beta2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients. [2006.08.18]
EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. [2006.07]
Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics. [2006.06.19]
Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses. [2006.06]
Beclomethasone dipropionate attenuates airways hyperresponsiveness to neurokinin A and histamine in asthma. [2006.06]
Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children. [2006.05]
Responses to inhaled bronchodilators in infancy are not linked with asthma in later childhood. [2006.05]
The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma. [2006.05]
Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. [2006.04.01]
Airway blood flow reactivity in healthy smokers and in ex-smokers with or without COPD. [2006.04]
Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma. [2006.04]
Safety and tolerability of high-dose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary disease. [2006.04]
beta-Adrenergic receptor polymorphisms and response to salmeterol. [2006.03.01]
Short-term lower leg growth in asthmatic children treated with inhaled beta2-agonists. [2006.03]
Effectiveness of nebulized furosemide added to nebulized salbutamol in children with acute asthma. [2006.03]
Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. [2006.03]
[Metered-dose inhaler with spacer vs nebulization for severe and potentially severe acute asthma treatment in the pediatric emergency department] [2006.03]
|
